Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR2 | Q92731 | 1/20 | 0.52 |
| ▸ | CA12 | O43570 | 1/20 | 0.52 |
| ▸ | CA1 | P00915 | 1/20 | 0.52 |
| ▸ | CA2 | P00918 | 1/20 | 0.52 |
| ▸ | CA9 | Q16790 | 1/20 | 0.52 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.52 |
| ▸ | ENPP1 | P22413 | 1/20 | 0.52 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.50 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.47 |
| ▸ | HPGD | P15428 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 1/20 | 0.47 |
| ▸ | RAB9A | P51151 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.46 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.46 |
| ▸ | BCL2L1 | Q07817 | 1/20 | 0.46 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.46 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Tannin Pyrogallol SCHEMBL28281926 | 0.92 | CA12 (0.55) | ESR2CA12CA1CA2CA9 | |
| SCHEMBL3294993 | 0.92 | CA12 (0.55) | ESR2CA12CA1CA2CA9 | |
| SCHEMBL616 | 0.92 | ESR2 (0.54) | ESR2CA12CA1CA2CA9 | |
| SCHEMBL29706107 | 0.92 | ESR2 (0.54) | ESR2CA12CA1CA2CA9 | |
| Hydrogen Sulfide SCHEMBL27694678 | 0.90 | CA12 (0.53) | ESR2CA12CA1CA2CA9 | |
| Biphenyl SCHEMBL4603527 | 0.89 | ESR2 (0.52) | ESR2CA12CA1CA2CA9 | |
| Biphenyl SCHEMBL4733975 | 0.89 | ESR2 (0.52) | ESR2CA12CA1CA2CA9 | |
| Bromide SCHEMBL1925857 | 0.89 | ESR2 (0.52) | ESR2CA12CA1CA2CA9 | |
| Ammonia Solution, Strong SCHEMBL19032131 | 0.89 | ESR2 (0.52) | ESR2CA12CA1CA2CA9 | |
| Water SCHEMBL8948779 | 0.89 | ESR2 (0.52) | ESR2CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 85 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | SHELL OIL COMPANY | 2001-11-08 | — | — | US | claimed |
| EP-0162706-B1 | POLYMER FILM WITH CONDUCTIVE PATTERN AND METHOD OF MANUFACTURING THE SAME | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1991-02-27 | — | — | EP | claimed |
| EP-0162706-A2 | Polymer film with conductive pattern and method of manufacturing the same | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1985-11-27 | — | — | EP | claimed |
| JP-6032746-A | — | — | None | — | — | JP | disclosed |
| JP-2011661-A | — | — | None | — | — | JP | disclosed |
| JP-2011661-A | — | — | None | — | — | JP | disclosed |
| CN-122050243-A | Calorimetric tag and preparation method and application method thereof | 苏州华实热敏科技有限公司 | 2026-05-15 | — | — | CN | disclosed |
| US-20210393634-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES WHICH CONTAINS PYRROLOPYRIMIDINE COMPOUND AS ACTIVE INGREDIENT | KEIO UNIVERSITY (JP) | 2021-12-23 | — | — | US | disclosed |
| EP-3821893-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES WHICH CONTAINS PYRROLOPYRIMIDINE COMPOUND AS ACTIVE INGREDIENT | Keio University (JP) | 2021-05-19 | — | — | EP | disclosed |
| WO-2019216409-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES WHICH CONTAINS PYRROLOPYRIMIDINE COMPOUND AS ACTIVE INGREDIENT | 学校法人慶應義塾 (JP) | 2019-11-14 | — | — | WO | disclosed |
| CN-106795000-B | The method for preparing zeolite SSZ-52 | 雪佛龙美国公司 | 2018-09-04 | — | — | CN | disclosed |
| EP-0295144-A1 | Optical recording medium | CANON KABUSHIKI KAISHA (JP) | 1988-12-14 | — | — | EP | disclosed |
| EP-0247366-A1 | Electrically conducting polymer film and method of manufacturing the same | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1987-12-02 | — | — | EP | disclosed |
| EP-0147915-B1 | NEW AZULENE DERIVATIVES USEFUL AS ANTI-ULCERATIVE AND ANTI-FLAMMATORY AGENTS | Kotobuki Seiyaku Co., Ltd. (JP) | 1987-05-06 | — | — | EP | disclosed |
| US-4608129-A | FORMING DIELECTRIC OVER PATTERNED ELECTRODE, DIFFUSION AROMATIC CO | NIPPON TELEGRAPHY AND TELEPHONE (JP) | 1986-08-26 | — | — | US | disclosed |
| US-4595694-A | Peptic ulcer treatment | KOTOBUKI SEIYAKU CO. LTD. (JP) | 1986-06-17 | — | — | US | disclosed |
| US-4559112-A | INSULATING POLUMER FILM OF SURFACE OF ELECTRODE AROMATIC POLYMER FORMEDAT INTERFACE BETWEEN/ FILM AND ELECTRODE | NIPPON TELEGRAPH & TELEPHONE (JP) | 1985-12-17 | — | — | US | disclosed |
| EP-0162706-A2 | Polymer film with conductive pattern and method of manufacturing the same | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1985-11-27 | — | — | EP | disclosed |
| EP-0147915-A1 | New azulene derivatives useful as anti-ulcerative and anti-flammatory agents | Kotobuki Seiyaku Co., Ltd. (JP) | 1985-07-10 | — | — | EP | disclosed |
| EP-0144127-A1 | Electrically conducting polymer film and method of manufacturing the same | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1985-06-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210393634-A1 | PROPHYLACTIC AND/OR THERAPEUTIC AGENT FOR INFLAMMATORY DISEASES WHICH CONTAINS PYRROLOPYRIMIDINE COMPOUND AS ACTIVE INGREDIENT | TPMT, IL1B, TSLP | ESR2 4683/4885CA12 1916/4885CA1 1749/4885 |
| US-20010039349-A1 | Selective, Catalytic, thermal functionalization of secondary or aromatic C-H cyclic hydrocarbon bonds | AHR, PAH, HRH3 | ESR2 892/4885CA12 695/4885CA1 2185/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.